Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Pharma Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Regular | Regular |
| Fund house | Nippon India | ICICI Pru |
| NAV | ₹591.2429 | ₹11.1100 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 20.6 years | 1.9 years |
| Expense ratio | 1.8% | 2.9% |
| Stars | ★★★★★ | Not rated |
| Growth Score | 78.10 | — |
Returns
| Nippon India Pharma Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| 1 month | +11.32% | +10.55% |
| 3 months | +3.52% | +5.11% |
| 6 months | +8.09% | +7.03% |
| YTD | +16.05% | +0.27% |
| 1 year | +14.27% | +0.73% |
| 3 years (CAGR) | +16.91% | — |
| 5 years (CAGR) | +14.37% | — |
| 10 years (CAGR) | +15.58% | — |
| Since launch | +17.64% | +5.50% |
Risk
| Nippon India Pharma Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| Volatility | 14.1% | — |
| Downside volatility | 9.1% | — |
| Sharpe | 0.74 | — |
| Sortino | 1.15 | — |
| Calmar | 1.14 | — |
| Return / risk | 1.20 | — |
| Deepest fall | −47.36% | −14.20% |
| Days to recover | 301 | — |
| Below its high | +0.00% | −0.80% |
Against benchmark
| Nippon India Pharma Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| Alpha | −2.75% | — |
| Beta | 0.89 | — |
| R² | 89.5% | — |
| Up capture | 83.5% | — |
| Down capture | 91.2% | — |
| Tracking error | 4.8% | — |
| Information ratio | −0.88 | — |
| Treynor | 0.11 | — |
Consistency
| Nippon India Pharma Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| Best 1-year | +175.79% | +15.87% |
| Middle 1-year | +13.84% | +0.73% |
| Worst 1-year | −36.67% | −9.27% |
| 1-year periods with a loss | 23.4% | 40.4% |
| Middle 3-year | +20.93% | — |
| Positive months | 63.9% | — |
| Best day | +3.40% | +3.52% |
| Worst day | −3.21% | −3.04% |
| Worst 5% day | −1.38% | −1.22% |
| Positive days | 53.7% | 45.5% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Nippon India Pharma Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| 5-year XIRR | +17.18% | — |
| 5-year value | ₹9,29,284 | — |
| 3-year XIRR | +13.26% | — |
| 1-year XIRR | +21.05% | +9.50% |
Holdings overlap i
| Nippon India Pharma Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| Nippon India Pharma Fund | — | 5% |
| ICICI Prudential Equity Minimum Variance Fund | 5% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | Nippon India Pharma Fund | ICICI Prudential Equity Minimum Variance Fund |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 5.10% | 2.82% |
| Sun Pharmaceutical Industries Limited | 11.55% | 2.19% |
| Max Healthcare Institute Limited | 3.31% | 0.39% |
Sectors and company size
| Nippon India Pharma Fund | ICICI Prudential Equity Minimum Variance Fund | |
|---|---|---|
| Large companies | 29.6% | 86.5% |
| Mid companies | 40.8% | 0.4% |
| Small companies | 28.7% | — |
| Top 10 holdings | 57.2% | 58.0% |
| Largest sector | Pharmaceuticals & Biotechnology 75% | Banks 23% |